Pt Kalbe Farma Tbk (Indonesia)

Quote Chart
Quote Summary
Last Price 1,355.00
Volume 80,382,500
Turnover 108,516,375,000
Index    Jakarta Composite Index
Market Indonesia Stock Exchange
Ticker KLBF
Market Cap Market Cap 63,515,790,310
52 Week High 1,905.00
52 Week Low 1,185.00
P/E 30.76
EPS 44.05
Dividend Yield 19 (December 31, 2012)
Bookvalue 12,128,903,561
Enterprise Value 61,917,309,588
Quote updated on February 05, 2016
Note: data in IDR Thousands.
Select Items to chart them. 2015 Q3C
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
Net Profit(Loss)
Total Assets 13,259,344,410
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Consolidated
Source: World's Vest Base, EMIS Company Database.
Company Description

PT. Kalbe Farma Tbk. (KLBF) operates as a pharmaceuticals manufacturer with approximately 400 brands of pharmaceutical products. KLBF retains strategic alliances through its licensing agreements with some of the world pharmaceutical companies, including Fujisawa Pharmaceutical Co., Ltd., Bristol Myers Squibb, Baxter and Pharmacia Upjohn. KLBF was listed on Indonesia Stock Exchange in 1991 under the Main Board. The company was founded in 1966, with the head office located in Jakarta and factory in Bekasi,…

Main Products

Pharmaceutical products

Contact Information

Legal Address
Kalbe Building,Jl. Letjend. Suprapto Kav. 4,P.O. Box 3106 Jak
Jakarta; Jakarta; Map
Postal Code: 10510
Tel: +62-21-4287-3888
Fax: +62-21-4287-3680

Full name: Pt Kalbe Farma Tbk

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
ISIN Code: ID1000096803
Incorporation Date: 1966

Basic Information
Total Employees:
Outstanding Shares:
: ()
Financial Auditors:
Key Executives
Ownership Details
Pt Diptanala Bahana - IDR50
Affiliates and related companies
PT. Bintang Toedjoe
Corporate Actions
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Financial Documents/Annual Reports
Competitors - Indonesia

Register Your Interest

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.